Cover Image
市場調查報告書

ImmunNovative Developments SL的產品平台分析

ImmunNovative Developments SL - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 319980
出版日期 內容資訊 英文 18 Pages
訂單完成後即時交付
價格
Back to Top
ImmunNovative Developments SL的產品平台分析 ImmunNovative Developments SL - Product Pipeline Review - 2014
出版日期: 2014年11月24日 內容資訊: 英文 18 Pages
簡介

ImmunNovative Developments SL是總公司在西班牙的生物科技企業,從事治療、診斷、預防多重抗藥性細菌的感染疾病,及免疫來源的發炎疾病的新生技藥品的藥物研發、開發。該公司著重的產品為IND-006和IND-005,各種細菌及真菌造成的敗血症的治療藥。

本報告提供ImmunNovative Developments SL的治療藥開發平台的現狀及各開發階段比較分析、各藥物標靶、作用機制、給藥途徑、分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

目錄

ImmunNovative Developments SL的基本資料

  • ImmunNovative Developments SL概要
  • 主要資訊
  • 企業資料

ImmunNovative Developments SL:R&D概要

  • 主要的治療範圍

ImmunNovative Developments SL:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

ImmunNovative Developments SL:開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發階段的產品/聯合治療模式

ImmunNovative Developments SL:藥物簡介

  • ImmunNovative-01
  • ImmunNovative-02
  • IND-005
  • IND-006

ImmunNovative Developments SL:開發平台分析

  • 各分子類型

ImmunNovative Developments SL:總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

目錄
Product Code: GMDHC06547CDB

Summary

Global Markets Direct's, 'ImmunNovative Developments SL - Product Pipeline Review - 2014', provides an overview of the ImmunNovative Developments SL's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of ImmunNovative Developments SL's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of ImmunNovative Developments SL including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of ImmunNovative Developments SL's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the ImmunNovative Developments SL's pipeline products

Reasons to buy

  • Evaluate ImmunNovative Developments SL's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of ImmunNovative Developments SL in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the ImmunNovative Developments SL's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of ImmunNovative Developments SL and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of ImmunNovative Developments SL
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of ImmunNovative Developments SL and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • ImmunNovative Developments SL Snapshot
    • ImmunNovative Developments SL Overview
    • Key Information
    • Key Facts
  • ImmunNovative Developments SL - Research and Development Overview
    • Key Therapeutic Areas
  • ImmunNovative Developments SL - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • ImmunNovative Developments SL - Pipeline Products Glance
    • ImmunNovative Developments SL - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • ImmunNovative Developments SL - Drug Profiles
    • ImmunNovative-01
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ImmunNovative-02
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • IND-005
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • IND-006
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • ImmunNovative Developments SL - Pipeline Analysis
  • ImmunNovative Developments SL - Pipeline Products by Molecule Type
  • ImmunNovative Developments SL - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • ImmunNovative Developments SL, Key Information
  • ImmunNovative Developments SL, Key Facts
  • ImmunNovative Developments SL - Pipeline by Indication, 2014
  • ImmunNovative Developments SL - Pipeline by Stage of Development, 2014
  • ImmunNovative Developments SL - Monotherapy Products in Pipeline, 2014
  • ImmunNovative Developments SL - Preclinical, 2014
  • ImmunNovative Developments SL - Discovery, 2014
  • ImmunNovative Developments SL - Pipeline by Molecule Type, 2014

List of Figures

  • ImmunNovative Developments SL - Pipeline by Top 10 Indication, 2014
  • ImmunNovative Developments SL - Pipeline by Stage of Development, 2014
  • ImmunNovative Developments SL - Monotherapy Products in Pipeline, 2014
  • ImmunNovative Developments SL - Pipeline by Top 10 Molecule Type, 2014
Back to Top